Pharmacists in Mamaroneck, New York


12 Pharmacists found in Mamaroneck
female pharmacist

Celeste Jean Staropoli, RPH


Pharmacist
275 Mamaroneck Ave, Mamaroneck, NY 10543
914-381-4550    

female pharmacist

Mrs. Cheryl Crick, RPH


Pharmacist
275 Mamaroneck Avenue, Mamaroneck, NY 10543
914-381-4550     914-381-2521

female pharmacist

Mrs. Donna M Gallucci, RPH, M.S.


Pharmacist
845 Palmer Ave, Mamaroneck, NY 10543
914-864-5191     914-864-5195



male pharmacist

Mr. Edward F Carpenter, R.PH.


Pharmacist
845 Palmer Ave, Jewish Home Lifecare, Mamaroneck, NY 10543
914-864-5191    

female pharmacist

Gabriella Sitner-medvedovsky


Pharmacist
907 Palmer Ave Apt H4, Mamaroneck, NY 10543
646-306-5236    

male pharmacist

Mr. Gary P Tenenzapf, RPH MS


Pharmacist
225 Mamaroneck Ave, Pharmacy Dept, Mamaroneck, NY 10543
914-381-4550    

female pharmacist

Ms. Joanne Lohn, R.PH.


Pharmacist
845 Palmer Ave, Mamaroneck, NY 10543
914-864-5191     914-864-5195

female pharmacist

Ms. Ketty Gracia, RPH


Pharmacist
275 Mamaroneck Ave, Mamaroneck, NY 10543
914-381-4550     914-381-2521

female pharmacist

Maddalena Pecini, PHARM.D.


Pharmacist
845 Palmer Ave, Mamaroneck, NY 10543
914-864-5191     914-864-9195

female pharmacist

Nital Patel, RPH


Pharmacist
1100 E Boston Post Rd, Mamaroneck, NY 10543
914-698-3418    

male pharmacist

Mr. Philip Deluccia, R.PH.


Pharmacist
1100 E Boston Post Rd, Mamaroneck, NY 10543
914-698-3414     914-698-2616

female pharmacist

Dr. Sophia Liristis, PHARM D


Pharmacist
430 Mamaroneck Ave, Mamaroneck, NY 10543
914-600-8321     914-600-8322


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.